NeuroMetrix (NURO) 10-K2020 FY Annual report

Filed: 27 Jan 22, 9:48pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: accrual, administered, alleviated, altogether, aspect, Baker, BDD, blend, blind, Breakthrough, chemotherapy, CIPN, comparison, composite, COPC, coupled, depict, descending, disadvantaged, double, elevated, enrolled, erosion, expiry, extremity, FIQR, forfeited, ideally, inconclusive, inflation, interactive, ITT, landlord, leverage, leveraging, limb, loyal, NCI, neuromodulation, neurotherapeutic, nonclinical, phone, pivotal, procurement, progressed, pronounced, QST, quantify, Questionnaire, ratio, recapitalization, replicate, restoration, RLS, Rx, sham, Similarly, slightly, staffing, subgroup, suspended, task, thousand, Tilly

Removed: applied, assumed, assuming, bear, book, carried, comparable, computing, converted, distributed, eighteen, entirety, excluding, exist, explanatory, fall, Farma, FDIC, feel, GlaxoSmithKline, handled, ineffective, informing, innovate, Internationally, invoice, invoiced, manager, month, neoprene, neurotechnology, paragraph, preclude, prepared, pursuing, recently, recovered, release, relocation, requisite, satisfaction, Scienta, shift, suffered, sustained, text, unanticipated, varying

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated NURO transcripts

NURO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-118059, 333-135242, 333-151195, 333-159712, 333-159713, 333-167180, 333-173769, 333-183071, 333-186827, 333-189393, 333-190177 333-197407, 333-205827, 333-211379, 333-218431, 333-226245,333-236105 and 333-256489) and on Form S-3 (Nos. 333-150087, 333-162303, 333-165784 333-186855, 333-189392, 333-197405, 333-199359, 333-208923, 333-209528, 333-211919, 333-215792, 333-219783, 333-229349 and 333-260438) of our report dated January 27, 2022 relating to the financial statements and schedule of NeuroMetrix, Inc. (the Company), as of and for the years ended December 31, 2021 and 2020, which appears in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

/s/ Baker Tilly US, LLP

Baker Tilly US, LLP

Tewksbury, Massachusetts
January 27, 2022